Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.

Saved in:
Bibliographic Details
Title: Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
Authors: Durier C; INSERM US19, Villejuif, France. christine.durier@inserm.fr., Ninove L; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., Lefebvre M; Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles CHU de Nantes, INSERM CIC1413, Nantes, France., Radenne A; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France., Desaint C; INSERM US19, Villejuif, France.; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Ropers J; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France., Bauer R; INSERM US19, Villejuif, France., Lebbah S; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France., Carette D; INSERM US19, Villejuif, France., Lachatre M; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Lecompte AS; Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles CHU de Nantes, INSERM CIC1413, Nantes, France., Deplanque D; INSERM, CHU Lille, CIC 1403 - Centre d'investigation Clinique, Univ. Lille, Lille, France., Botelho-Nevers E; Infectious Diseases Department, CIC 1408 INSERM University Hospital of Saint-Etienne, University Hospital of Saint-Etienne, Saint-Etienne, France., Conrad A; Department Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Univ. Claude Bernard Lyon I, CNRS, UMR5308, ENS de Lyon, Univ Lyon, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France., Dussol B; Centre d'Investigation Clinique 1409, Hôpital de la Conception, INSERM- Hôpitaux Universitaires de Marseille - Aix Marseille Université, Marseille, France., Maakaroun-Vermesse Z; Centre de Vaccination CHU de Tours, Centre d'Investigation Clinique CIC 1415, INSERM, CHRU de Tours, Tours, France., Melica G; Service d'Immunologie Clinique et Maladies Infectieuses, APHP, Hôpital Henri Mondor, Créteil, France.; Centre d'Investigation Clinique 1430 INSERM, APHP, Hôpital Henri Mondor, Créteil, France., Nicolas JF; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France.; CHU Lyon-Sud, Pierre-Bénite, France., Verdon R; Service de Maladies Infectieuses, CHU de Caen, Caen, France.; Dynamicure INSERM, UMR 1311, Normandie Univ, UNICAEN, Caen, France., Kiladjian J; AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Université Paris Cité, Paris, France., Loubet P; VBMI, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, CHU Nîmes, Univ Montpellier, Nîmes, France., Schmidt-Mutter C; Inserm CIC 1434, CHU Strasbourg, Strasbourg, France., Dualé C; Centre d'Investigation Clinique (INSERM CIC1405), CHU Clermont-Ferrand, Clermont-Ferrand, France., Ansart S; Centre d'Investigation Clinique CIC 1412, INSERM, CHU Brest, Brest, France., Priet S; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., Levier A; ANRS | Emerging Infectious Diseases, Paris, France., Molino D; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Vieillard LV; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France., Parfait B; Fédération des Centres de Ressources Biologiques - Plateforme de Ressources Biologiques APHP -Université de Paris, Centre de Ressources Biologiques Cochin, Hôpital Cochin, Paris, France., Lelièvre JD; INSERM U955, Vaccine Research Institute, Créteil, France., Tartour E; APHP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Université de Paris, Paris, France., de Lamballerie X; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France., Launay O; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.
Corporate Authors: ANRS0002S CoviCompareP Group, AP-HP CoviCompareM Group, Biological resource centers, Laboratories, Trial coordination, Sponsor, Scientific Committee
Source: Scientific reports [Sci Rep] 2022 Nov 27; Vol. 12 (1), pp. 20373. Date of Electronic Publication: 2022 Nov 27.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36437298
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Durier+C%22">Durier C</searchLink>; INSERM US19, Villejuif, France. christine.durier@inserm.fr.<br /><searchLink fieldCode="AU" term="%22Ninove+L%22">Ninove L</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Lefebvre+M%22">Lefebvre M</searchLink>; Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles CHU de Nantes, INSERM CIC1413, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Radenne+A%22">Radenne A</searchLink>; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France.<br /><searchLink fieldCode="AU" term="%22Desaint+C%22">Desaint C</searchLink>; INSERM US19, Villejuif, France.; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Ropers+J%22">Ropers J</searchLink>; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France.<br /><searchLink fieldCode="AU" term="%22Bauer+R%22">Bauer R</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Lebbah+S%22">Lebbah S</searchLink>; Assistance Publique Hôpitaux de Paris, Unité de Recherche Clinique des Hôpitaux Universitaires Pitié Salpêtrière -Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France.<br /><searchLink fieldCode="AU" term="%22Carette+D%22">Carette D</searchLink>; INSERM US19, Villejuif, France.<br /><searchLink fieldCode="AU" term="%22Lachatre+M%22">Lachatre M</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lecompte+AS%22">Lecompte AS</searchLink>; Maladies Infectieuses et Tropicales, Centre de Prévention des Maladies Infectieuses et Transmissibles CHU de Nantes, INSERM CIC1413, Nantes, France.<br /><searchLink fieldCode="AU" term="%22Deplanque+D%22">Deplanque D</searchLink>; INSERM, CHU Lille, CIC 1403 - Centre d'investigation Clinique, Univ. Lille, Lille, France.<br /><searchLink fieldCode="AU" term="%22Botelho-Nevers+E%22">Botelho-Nevers E</searchLink>; Infectious Diseases Department, CIC 1408 INSERM University Hospital of Saint-Etienne, University Hospital of Saint-Etienne, Saint-Etienne, France.<br /><searchLink fieldCode="AU" term="%22Conrad+A%22">Conrad A</searchLink>; Department Maladies Infectieuses et Tropicales, Hôpital de la Croix-Rousse, Hospices Civils de Lyon, Univ. Claude Bernard Lyon I, CNRS, UMR5308, ENS de Lyon, Univ Lyon, Lyon, France.; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France.<br /><searchLink fieldCode="AU" term="%22Dussol+B%22">Dussol B</searchLink>; Centre d'Investigation Clinique 1409, Hôpital de la Conception, INSERM- Hôpitaux Universitaires de Marseille - Aix Marseille Université, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Maakaroun-Vermesse+Z%22">Maakaroun-Vermesse Z</searchLink>; Centre de Vaccination CHU de Tours, Centre d'Investigation Clinique CIC 1415, INSERM, CHRU de Tours, Tours, France.<br /><searchLink fieldCode="AU" term="%22Melica+G%22">Melica G</searchLink>; Service d'Immunologie Clinique et Maladies Infectieuses, APHP, Hôpital Henri Mondor, Créteil, France.; Centre d'Investigation Clinique 1430 INSERM, APHP, Hôpital Henri Mondor, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Nicolas+JF%22">Nicolas JF</searchLink>; Centre International de Recherche en Infectiologie (CIRI), INSERM U1111, Université Claude Bernard Lyon I, Lyon, France.; CHU Lyon-Sud, Pierre-Bénite, France.<br /><searchLink fieldCode="AU" term="%22Verdon+R%22">Verdon R</searchLink>; Service de Maladies Infectieuses, CHU de Caen, Caen, France.; Dynamicure INSERM, UMR 1311, Normandie Univ, UNICAEN, Caen, France.<br /><searchLink fieldCode="AU" term="%22Kiladjian+J%22">Kiladjian J</searchLink>; AP-HP, Hôpital Saint-Louis, Centre d'Investigations Cliniques, INSERM, CIC1427, Université Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Loubet+P%22">Loubet P</searchLink>; VBMI, INSERM U1047, Department of Infectious and Tropical Diseases, Université de Montpellier, CHU Nîmes, Univ Montpellier, Nîmes, France.<br /><searchLink fieldCode="AU" term="%22Schmidt-Mutter+C%22">Schmidt-Mutter C</searchLink>; Inserm CIC 1434, CHU Strasbourg, Strasbourg, France.<br /><searchLink fieldCode="AU" term="%22Dualé+C%22">Dualé C</searchLink>; Centre d'Investigation Clinique (INSERM CIC1405), CHU Clermont-Ferrand, Clermont-Ferrand, France.<br /><searchLink fieldCode="AU" term="%22Ansart+S%22">Ansart S</searchLink>; Centre d'Investigation Clinique CIC 1412, INSERM, CHU Brest, Brest, France.<br /><searchLink fieldCode="AU" term="%22Priet+S%22">Priet S</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Levier+A%22">Levier A</searchLink>; ANRS | Emerging Infectious Diseases, Paris, France.<br /><searchLink fieldCode="AU" term="%22Molino+D%22">Molino D</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Vieillard+LV%22">Vieillard LV</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.<br /><searchLink fieldCode="AU" term="%22Parfait+B%22">Parfait B</searchLink>; Fédération des Centres de Ressources Biologiques - Plateforme de Ressources Biologiques APHP -Université de Paris, Centre de Ressources Biologiques Cochin, Hôpital Cochin, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lelièvre+JD%22">Lelièvre JD</searchLink>; INSERM U955, Vaccine Research Institute, Créteil, France.<br /><searchLink fieldCode="AU" term="%22Tartour+E%22">Tartour E</searchLink>; APHP, Hôpital Européen Georges Pompidou, INSERM U970, PARCC, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22de+Lamballerie+X%22">de Lamballerie X</searchLink>; Unité des Virus Émergents (UVE), Aix Marseille Univ, IRD 190, INSERM 1207, Marseille, France.<br /><searchLink fieldCode="AU" term="%22Launay+O%22">Launay O</searchLink>; INSERM CIC 1417 Cochin Pasteur, Assistance Publique Hôpitaux de Paris, Hôpital Cochin, Innovative Clinical Research Network in Vaccinology, Université de Paris, Sorbonne Paris Cité, Paris, France.
– Name: AuthorCorporate
  Label: Corporate Authors
  Group: Au
  Data: <searchLink fieldCode="CA" term="%22ANRS0002S+CoviCompareP+Group%22">ANRS0002S CoviCompareP Group</searchLink><br /><searchLink fieldCode="CA" term="%22AP-HP+CoviCompareM+Group%22">AP-HP CoviCompareM Group</searchLink><br /><searchLink fieldCode="CA" term="%22Biological+resource+centers%22">Biological resource centers</searchLink><br /><searchLink fieldCode="CA" term="%22Laboratories%22">Laboratories</searchLink><br /><searchLink fieldCode="CA" term="%22Trial+coordination%22">Trial coordination</searchLink><br /><searchLink fieldCode="CA" term="%22Sponsor%22">Sponsor</searchLink><br /><searchLink fieldCode="CA" term="%22Scientific+Committee%22">Scientific Committee</searchLink>
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101563288%22">Scientific reports</searchLink> [Sci Rep] 2022 Nov 27; Vol. 12 (1), pp. 20373. <i>Date of Electronic Publication: </i>2022 Nov 27.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101563288 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2045-2322 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220452322%22">20452322 </searchLink><i>NLM ISO Abbreviation: </i>Sci Rep <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36437298
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41598-022-24409-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 20373
    Titles:
      – TitleFull: Neutralizing antibodies against SARS-CoV-2 variants following mRNA booster vaccination in adults older than 65 years.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Durier C
      – PersonEntity:
          Name:
            NameFull: Ninove L
      – PersonEntity:
          Name:
            NameFull: Lefebvre M
      – PersonEntity:
          Name:
            NameFull: Radenne A
      – PersonEntity:
          Name:
            NameFull: Desaint C
      – PersonEntity:
          Name:
            NameFull: Ropers J
      – PersonEntity:
          Name:
            NameFull: Bauer R
      – PersonEntity:
          Name:
            NameFull: Lebbah S
      – PersonEntity:
          Name:
            NameFull: Carette D
      – PersonEntity:
          Name:
            NameFull: Lachatre M
      – PersonEntity:
          Name:
            NameFull: Lecompte AS
      – PersonEntity:
          Name:
            NameFull: Deplanque D
      – PersonEntity:
          Name:
            NameFull: Botelho-Nevers E
      – PersonEntity:
          Name:
            NameFull: Conrad A
      – PersonEntity:
          Name:
            NameFull: Dussol B
      – PersonEntity:
          Name:
            NameFull: Maakaroun-Vermesse Z
      – PersonEntity:
          Name:
            NameFull: Melica G
      – PersonEntity:
          Name:
            NameFull: Nicolas JF
      – PersonEntity:
          Name:
            NameFull: Verdon R
      – PersonEntity:
          Name:
            NameFull: Kiladjian J
      – PersonEntity:
          Name:
            NameFull: Loubet P
      – PersonEntity:
          Name:
            NameFull: Schmidt-Mutter C
      – PersonEntity:
          Name:
            NameFull: Dualé C
      – PersonEntity:
          Name:
            NameFull: Ansart S
      – PersonEntity:
          Name:
            NameFull: Priet S
      – PersonEntity:
          Name:
            NameFull: Levier A
      – PersonEntity:
          Name:
            NameFull: Molino D
      – PersonEntity:
          Name:
            NameFull: Vieillard LV
      – PersonEntity:
          Name:
            NameFull: Parfait B
      – PersonEntity:
          Name:
            NameFull: Lelièvre JD
      – PersonEntity:
          Name:
            NameFull: Tartour E
      – PersonEntity:
          Name:
            NameFull: de Lamballerie X
      – PersonEntity:
          Name:
            NameFull: Launay O
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 11
              Text: 2022 Nov 27
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2045-2322
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Scientific reports
              Type: main
ResultId 1